Dyne Therapeutics, Inc. · NASDAQ:DYN

Rhodes Jason P sold 2,586,928 Dyne Therapeutics, Inc. shares (Form 4)

Traded Aug 13 to Aug 14, 2026 · Filed Aug 17, 2026

From Aug 13 to Aug 14, 2026, Rhodes Jason P (Director) sold 2,586,928 Dyne Therapeutics, Inc. shares at an average US$25.20 for US$65.2M under a trading plan, leaving 428,946 shares. Filed Aug 17, 2026 (Form 4).

Sold
2,586,928 shares
Price
US$25.20 average (US$25.00 to US$26.20)
Value
US$65.2M
Holding after
428,946 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 13, 2026Common StockSale268,354US$26.203,801,128Indirect
Aug 13, 2026Common StockSale94,415US$26.201,045,735Indirect
Aug 13, 2026Common StockSale63,643US$26.20751,411Indirect
Aug 14, 2026Common StockSale1,359,674US$25.002,441,454Indirect
Aug 14, 2026Common StockSale478,377US$25.00567,358Indirect
Aug 14, 2026Common StockSale322,465US$25.00428,946Indirect

Source

View original at SEC

Related